Page last updated: 2024-10-29

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Acute Disease

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline has been researched along with Acute Disease in 4 studies

WHI P131: a quinazoline derivative, inhibitor of glioblastoma cell adhesion and migration

Acute Disease: Disease having a short and relatively severe course.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Uckun, FM3
Tibbles, H1
Ozer, Z1
Qazi, S1
Vassilev, A1
Pan, L1
Peng, Z1
Zhang, R2
Liang, D1
Chen, H1
Tian, H1
Cetkovic-Cvrlje, M2
Roers, BA1
Waurzyniak, B1
Liu, XP1

Other Studies

4 other studies available for 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Acute Disease

ArticleYear
Anti-inflammatory activity profile of JANEX-1 in preclinical animal models.
    Bioorganic & medicinal chemistry, 2008, Feb-01, Volume: 16, Issue:3

    Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Cell Line; Disease Models, Animal; Drug Evaluation

2008
JANEX-1 improves acute pulmonary embolism through VEGF and FAK in pulmonary artery smooth muscle cells.
    Experimental biology and medicine (Maywood, N.J.), 2020, Volume: 245, Issue:15

    Topics: Acute Disease; Animals; Cell Proliferation; Disease Models, Animal; Focal Adhesion Protein-Tyrosine

2020
Dual targeting of Bruton's tyrosine kinase and Janus kinase 3 with rationally designed inhibitors prevents graft-versus-host disease (GVHD) in a murine allogeneic bone marrow transplantation model.
    British journal of haematology, 2004, Volume: 126, Issue:6

    Topics: Acute Disease; Agammaglobulinaemia Tyrosine Kinase; Amides; Animals; Bone Marrow Transplantation; Dr

2004
Targeting Janus kinase 3 to attenuate the severity of acute graft-versus-host disease across the major histocompatibility barrier in mice.
    Blood, 2001, Sep-01, Volume: 98, Issue:5

    Topics: Acute Disease; Animals; Bone Marrow Transplantation; Cell Transplantation; Drug Evaluation, Preclini

2001